Graft-Versus-Host Disease Prophylaxis with Posttransplantation Cyclophosphamide and Ruxolitinib in Patients with Myelofibrosis

被引：0
|
作者：
Morozova, Elena V.
Moiseev, Ivan S.
Barabanshikova, Maria V.
Darskaya, Elena I.
Bondarenko, Sergey N.
Zubarovskaya, Ludmila S.
Baykov, Vadim
Alyanski, Alexandr L.
Barkhatov, Ildar M.
Zander, Axel R.
Afanasyev, Boris V.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4492
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation
    Mielcarek, Marco
    Furlong, Terry
    O'Donnell, Paul V.
    Storer, Barry E.
    McCune, Jeannine S.
    Storb, Rainer
    Carpenter, Paul A.
    Flowers, Mary E. D.
    Appelbaum, Frederick R.
    Martin, Paul J.
    BLOOD, 2016, 127 (11) : 1502 - 1508
  • [42] Short-term KRP203 and posttransplant cyclophosphamide for graft-versus-host disease prophylaxis
    Yokoyama, Emi
    Hashimoto, Daigo
    Ara, Takahide
    Hayase, Eko
    Teshima, Takanori
    BONE MARROW TRANSPLANTATION, 2019, 54 : 337 - 337
  • [43] Short-term KRP203 and posttransplant cyclophosphamide for graft-versus-host disease prophylaxis
    Emi Yokoyama
    Daigo Hashimoto
    Eiko Hayase
    Takahide Ara
    Reiki Ogasawara
    Shuichiro Takahashi
    Hiroyuki Ohigashi
    Takahiro Tateno
    Yuta Hasegawa
    Xuanzhong Chen
    Takanori Teshima
    Bone Marrow Transplantation, 2020, 55 : 787 - 795
  • [44] Short-term KRP203 and posttransplant cyclophosphamide for graft-versus-host disease prophylaxis
    Yokoyama, Emi
    Hashimoto, Daigo
    Hayase, Eiko
    Ara, Takahide
    Ogasawara, Reiki
    Takahashi, Shuichiro
    Ohigashi, Hiroyuki
    Tateno, Takahiro
    Hasegawa, Yuta
    Chen, Xuanzhong
    Teshima, Takanori
    BONE MARROW TRANSPLANTATION, 2020, 55 (04) : 787 - 795
  • [45] Use of Ruxolitinib in Pediatric Patients with Steroid-Refractory Graft-versus-host Disease (GVHD)
    Becilli, Marco
    Merli, Pietro
    Pagliara, Daria
    Galaverna, Federica
    Algeri, Mattia
    Gaspari, Stefania
    Boccieri, Emilia
    Carta, Roberto
    Ruggeri, Annalisa
    Locatelli, Franco
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 631 - 631
  • [46] Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease
    Ullmann, Andrew J.
    Lipton, Jeffrey H.
    Vesole, David H.
    Chandrasekar, Pranatharthi
    Langston, Amelia
    Tarantolo, Stefano R.
    Greinix, Hildegard
    Morais de Azevedo, Wellington
    Reddy, Vijay
    Boparai, Navdeep
    Pedicone, Lisa
    Patino, Hernando
    Durrant, Simon
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (04): : 335 - 347
  • [47] New advances in acute graft-versus-host disease prophylaxis
    Davies, JK
    Lowdell, MW
    TRANSFUSION MEDICINE, 2003, 13 (06) : 387 - 397
  • [48] Drug therapy for acute graft-versus-host disease prophylaxis
    Simpson, D
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2000, 9 (03): : 317 - 325
  • [49] Use of Belimumab for Prophylaxis of Chronic Graft-Versus-Host Disease
    Pusic, Iskra
    Johanns, Tanner
    Sarantopoulos, Stefanie
    Record, Haley
    Zeisset, Kaitlynn
    Westervelt, Peter
    Cashen, Amanda F.
    Uy, Geoffrey L.
    Abboud, Camille, Sr.
    DiPersio, John F.
    BLOOD, 2021, 138
  • [50] PROPHYLAXIS AND TREATMENT OF GRAFT-VERSUS-HOST DISEASE (GVHD) WITH DRUGS
    DEEG, HJ
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 209 - 209
12345